Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabotegravir in Neonates Exposed to HIV-1
NCT07275606Phase 2Recruiting
- Sponsor
- ViiV Healthcare
- Start
- Apr 2026
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabotegravir in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Apr 2026; status: recruiting.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07275606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07275606.